220 related articles for article (PubMed ID: 23392295)
41. Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype.
Gabriel D; Gordon LB; Djabali K
PLoS One; 2016; 11(12):e0168988. PubMed ID: 28033363
[TBL] [Abstract][Full Text] [Related]
42. The truncated prelamin A in Hutchinson-Gilford progeria syndrome alters segregation of A-type and B-type lamin homopolymers.
Delbarre E; Tramier M; Coppey-Moisan M; Gaillard C; Courvalin JC; Buendia B
Hum Mol Genet; 2006 Apr; 15(7):1113-22. PubMed ID: 16481358
[TBL] [Abstract][Full Text] [Related]
43. Novel progerin-interactive partner proteins hnRNP E1, EGF, Mel 18, and UBC9 interact with lamin A/C.
Zhong N; Radu G; Ju W; Brown WT
Biochem Biophys Res Commun; 2005 Dec; 338(2):855-61. PubMed ID: 16248985
[TBL] [Abstract][Full Text] [Related]
44. Imbalanced nucleocytoskeletal connections create common polarity defects in progeria and physiological aging.
Chang W; Wang Y; Luxton GWG; Östlund C; Worman HJ; Gundersen GG
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3578-3583. PubMed ID: 30808750
[TBL] [Abstract][Full Text] [Related]
45. Increased susceptibility to oxidative stress- and ultraviolet A-induced apoptosis in fibroblasts in atypical progeroid syndrome/atypical Werner syndrome with LMNA mutation.
Motegi S; Uchiyama A; Yamada K; Ogino S; Yokoyama Y; Perera B; Takeuchi Y; Ishikawa O
Exp Dermatol; 2016 Aug; 25 Suppl 3():20-7. PubMed ID: 27539898
[TBL] [Abstract][Full Text] [Related]
46. Suppression of proliferative defects associated with processing-defective lamin A mutants by hTERT or inactivation of p53.
Kudlow BA; Stanfel MN; Burtner CR; Johnston ED; Kennedy BK
Mol Biol Cell; 2008 Dec; 19(12):5238-48. PubMed ID: 18843043
[TBL] [Abstract][Full Text] [Related]
47. Expression of progerin in aging mouse brains reveals structural nuclear abnormalities without detectible significant alterations in gene expression, hippocampal stem cells or behavior.
Baek JH; Schmidt E; Viceconte N; Strandgren C; Pernold K; Richard TJ; Van Leeuwen FW; Dantuma NP; Damberg P; Hultenby K; Ulfhake B; Mugnaini E; Rozell B; Eriksson M
Hum Mol Genet; 2015 Mar; 24(5):1305-21. PubMed ID: 25343989
[TBL] [Abstract][Full Text] [Related]
48. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence.
Benson EK; Lee SW; Aaronson SA
J Cell Sci; 2010 Aug; 123(Pt 15):2605-12. PubMed ID: 20605919
[TBL] [Abstract][Full Text] [Related]
49. Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging?
Ashapkin VV; Kutueva LI; Kurchashova SY; Kireev II
Front Genet; 2019; 10():455. PubMed ID: 31156709
[TBL] [Abstract][Full Text] [Related]
50. A pathway linking oxidative stress and the Ran GTPase system in progeria.
Datta S; Snow CJ; Paschal BM
Mol Biol Cell; 2014 Apr; 25(8):1202-15. PubMed ID: 24523287
[TBL] [Abstract][Full Text] [Related]
51. UVA-induced upregulation of progerin suppresses 53BP1‑mediated NHEJ DSB repair in human keratinocytes via progerin-lamin A complex formation.
Huang X; Pan Y; Cao D; Fang S; Huang K; Chen J; Chen A
Oncol Rep; 2017 Jun; 37(6):3617-3624. PubMed ID: 28498430
[TBL] [Abstract][Full Text] [Related]
52. Increasing the length of progerin's isoprenyl anchor does not worsen bone disease or survival in mice with Hutchinson-Gilford progeria syndrome.
Davies BS; Yang SH; Farber E; Lee R; Buck SB; Andres DA; Spielmann HP; Agnew BJ; Tamanoi F; Fong LG; Young SG
J Lipid Res; 2009 Jan; 50(1):126-34. PubMed ID: 18757838
[TBL] [Abstract][Full Text] [Related]
53. Progerin elicits disease phenotypes of progeria in mice whether or not it is farnesylated.
Yang SH; Andres DA; Spielmann HP; Young SG; Fong LG
J Clin Invest; 2008 Oct; 118(10):3291-300. PubMed ID: 18769635
[TBL] [Abstract][Full Text] [Related]
54. Signaling pathway activation drift during aging: Hutchinson-Gilford Progeria Syndrome fibroblasts are comparable to normal middle-age and old-age cells.
Aliper AM; Csoka AB; Buzdin A; Jetka T; Roumiantsev S; Moskalev A; Zhavoronkov A
Aging (Albany NY); 2015 Jan; 7(1):26-37. PubMed ID: 25587796
[TBL] [Abstract][Full Text] [Related]
55. Repeated exposure of mouse dermal fibroblasts at a sub-cytotoxic dose of UVB leads to premature senescence: a robust model of cellular photoaging.
Zeng JP; Bi B; Chen L; Yang P; Guo Y; Zhou YQ; Liu TY
J Dermatol Sci; 2014 Jan; 73(1):49-56. PubMed ID: 24054498
[TBL] [Abstract][Full Text] [Related]
56. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing.
Scaffidi P; Misteli T
Nat Cell Biol; 2008 Apr; 10(4):452-9. PubMed ID: 18311132
[TBL] [Abstract][Full Text] [Related]
57. Metformin decreases progerin expression and alleviates pathological defects of Hutchinson-Gilford progeria syndrome cells.
Egesipe AL; Blondel S; Lo Cicero A; Jaskowiak AL; Navarro C; Sandre-Giovannoli A; Levy N; Peschanski M; Nissan X
NPJ Aging Mech Dis; 2016; 2():16026. PubMed ID: 28721276
[TBL] [Abstract][Full Text] [Related]
58. Defective extracellular pyrophosphate metabolism promotes vascular calcification in a mouse model of Hutchinson-Gilford progeria syndrome that is ameliorated on pyrophosphate treatment.
Villa-Bellosta R; Rivera-Torres J; Osorio FG; Acín-Pérez R; Enriquez JA; López-Otín C; Andrés V
Circulation; 2013 Jun; 127(24):2442-51. PubMed ID: 23690466
[TBL] [Abstract][Full Text] [Related]
59. Effect of progerin on the accumulation of oxidized proteins in fibroblasts from Hutchinson Gilford progeria patients.
Viteri G; Chung YW; Stadtman ER
Mech Ageing Dev; 2010 Jan; 131(1):2-8. PubMed ID: 19958786
[TBL] [Abstract][Full Text] [Related]
60. Autophagic degradation of farnesylated prelamin A as a therapeutic approach to lamin-linked progeria.
Cenni V; Capanni C; Columbaro M; Ortolani M; D'Apice MR; Novelli G; Fini M; Marmiroli S; Scarano E; Maraldi NM; Squarzoni S; Prencipe S; Lattanzi G
Eur J Histochem; 2011 Oct; 55(4):e36. PubMed ID: 22297442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
